I don't care. All I care about is revenue growth and sales numbers. I want them to spend their arses off to grow that sales line. As long as it isn't going to mgt in bonuses I'm ok with it. This is a high growth company and they need to spend. They need to invest heavily in staff, marketing and distribution. Breakeven is irrelevant in this phase of the company's life. They have plenty in the bank and if they spend it in the pusuit of high growth then I am happy with that. They will never grow quickly by cutting back on spending. We have 200m shares on issue and if in 2 years time we need some more cash then they can just go and raise it. This is a company with a small number of shares on issue.
- Forums
- ASX - By Stock
- YOW
- Ann: September 2016 Quarterly Report and Appendix 4C-YOW.AX
Ann: September 2016 Quarterly Report and Appendix 4C-YOW.AX, page-147
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add YOW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.734M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
YOW (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online